MOREPENLAB.NS
Key Ratios

Net Profit Margin: Making moderate profit when compared with its revenue which generally means a slow or stable business or a small company who just started making profit

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Inventory Turnover: Average efficiency of inventory movement, it varies by industry

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

P/E Ratio: A little overvalued stock but represent growth stock and possibility of future growth

Performance Graph
Financial Ratios
Ratio Value
PE Ratio40.22
Net Profit Margin0.06
Acid Test Ratio1.59
Inventory Turnover4.36
Coverage Ratio37.50
Debt to Equity0.03
Key Ratios

Net Profit Margin: Making moderate profit when compared with its revenue which generally means a slow or stable business or a small company who just started making profit

Return on Assets: Very high efficiency of the assets which indicates assets are making high contribution to the revenue

Return on Equity: Giving good returns on equity which is generally acceptable for most industries

Performance Graph
Profitability Ratios
Ratio Value
Net Profit Margin0.06
Return on Assets1.89
Return on Equity0.11
Performance Graph
Key Ratios

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Current Ratio: It would not have any issues to cover its short-term liabilities because of strong liquidity

Performance Graph
Liquidity Ratios
Ratio Value
Acid Test Ratio1.59
Current Ratio2.21
Performance Graph
Key Ratios

Inventory Turnover: Average efficiency of inventory movement, it varies by industry

Performance Graph
Efficiency Ratios
Ratio Value
Inventory Turnover4.36
Performance Graph
Key Ratios

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Performance Graph
Coverage Ratios
Ratio Value
Coverage Ratio37.50
Performance Graph
Key Ratios

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

Interest Coverage Ratio: Company is at low risk of getting default as it can easily cover its interest payments and strong financial health

Performance Graph
Solvency Ratios
Ratio Value
Debt to Equity Ratio0.03
Interest Coverage Ratio37.50
Performance Graph
Key Ratios

P/E Ratio: A little overvalued stock but represent growth stock and possibility of future growth

Dividend Yield: NA

Performance Graph
Market Ratios
Ratio Value
P/E Ratio40.22
Gross Profit Margin0.36
Price to Book Ratio4.56
Dividend Yield0.00
Performance Graph

Balance Sheet Analysis of Morepen Laboratories Limited

The balance sheet in the financial statement of the company shows its financial position at a particular point in time.

It consists of the following:

  • Assets: Something that the company owns and that gives financial benefits over a period of time.
  • Liabilities: Something that a company owes and that has a financial burden on the company.
  • Equity: It is basically the owner’s share in the company.

The formula is:

Assets = Liabilities + Equity
đź“ŚAssets:
Asset
Value & Year
2024
2023
2022
Total Assets 12932051000 11104951000 10700527000
Total Non Current Assets 4041611000 3543304000 3357516000
Other Non Current Assets 638844000 639177000 1000
Non Current Prepaid Assets 71567000 63933000 58669000
Non Current Deferred Taxes Assets - - -
Financial Assets - - -
Investment In Financial Assets 13010000 - -
Held To Maturity Securities - - -
Available For Sale Securities 84425000 63777000 -
Financial Assets Fair Value - - -
Long Term Equity Investment - - -
Investments In Associates At Cost - - -
Goodwill And Other Intangible Assets 943700000 1002334000 1054080000
Other Intangible Assets 198958000 257592000 309338000
Goodwill 744742000 744742000 744742000
Net Ppe 3012975000 2476542000 2244194000
Accumulated Depreciation -2614021000 -3289189000 -3166240000
Gross Ppe 5626996000 5765731000 5410434000
Construction In Progress 880934000 806552000 777723000
Other Properties 2132041000 1669990000 1466472000
Machinery Furniture Equipment 3735658000 4036130000 3804307000
Buildings And Improvements 996076000 908721000 814076000
Land And Improvements 14328000 14328000 14328000
Properties - - -
Current Assets 8890440000 7561647000 7343011000
Other Current Assets -3000 2019395000 -1000
Hedging Assets Current - - -
Assets Held For Sale Current - - -
Restricted Cash 351715000 346397000 301680000
Prepaid Assets 2568197000 2048496000 1583342000
Inventory 2485942000 2288863000 2758541000
Other Inventories - - -
Finished Goods 625497000 591289000 795205000
Work In Process 374137000 386455000 358217000
Raw Materials 1486308000 1311119000 1605119000
Other Receivables 65757000 28763000 34992000
Taxes Receivable - - -
Accounts Receivable 3249381000 2632470000 2506431000
Allowance For Doubtful Accounts Receivable -29362000 -27541000 -58287000
Gross Accounts Receivable 3278743000 2660011000 2564718000
Cash Cash Equivalents And Short Term Investments 169451000 216658000 158026000
Other Short Term Investments 495530000 401524000 352309000
Cash And Cash Equivalents 169451000 216658000 158026000
Cash Equivalents - - 11302000
Cash Financial 169451000 216658000 146724000
đź“Ś Liabilities & Equity
Liability/Equity
Value & Year
2024
2023
2022
Net Debt 120541000 34983000 27664000
Total Debt 289992000 251641000 185690000
Total Liabilities Net Minority Interest 4459789000 3580474000 4919522000
Total Non Current Liabilities Net Minority Interest 439343000 368843000 354953000
Other Non Current Liabilities - - -
Derivative Product Liabilities - - -
Non Current Pension And Other Postretirement Benefit Plans - 297446000 282445000
Trade And Other Payables Non Current - - -
Non Current Deferred Revenue - - -
Non Current Deferred Taxes Liabilities 22495000 26860000 24826000
Long Term Debt And Capital Lease Obligation 33640000 9335000 13211000
Long Term Capital Lease Obligation - - -
Long Term Debt 33640000 9335000 13211000
Long Term Provisions 338166000 297446000 282445000
Current Liabilities 4020446000 3211631000 4564569000
Other Current Liabilities 5782000 5782000 5786000
Current Deferred Taxes Liabilities - - -
Current Debt And Capital Lease Obligation 256352000 242306000 172479000
Current Capital Lease Obligation - - -
Current Debt 256352000 242306000 172479000
Pension And Other Post Retirement Benefit Plans Current - - -
Current Provisions 250150000 162411000 122369000
Payables 3184696000 2506707000 2631801000
Other Payable 197001000 221456000 -
Dividends Payable - - -
Total Tax Payable 37420000 16458000 50645000
Accounts Payable 2950275000 2268793000 2581156000
Common Stock Equity 8472262000 7529081000 5785612000
Total Capitalization 8505902000 7538416000 5798823000
Total Equity Gross Minority Interest 8472262000 7524477000 5781005000
Minority Interest - -4604000 -4607000
Stockholders Equity 8472262000 7529081000 5785612000
Other Equity Interest 7449991000 6506810000 262500000
Treasury Stock - - -
Retained Earnings 2861719000 1900120000 1513368000
Additional Paid In Capital 4460219000 4460219000 3080384000
Capital Stock 1022271000 1022271000 955586000
Common Stock 1022271000 1022271000 955586000

Income statement interpretation for Morepen Laboratories Limited

The income statement in the financial statement of the company shows its company financial performance over a period in time.

It consists of the following:

  • Revenue: It is the total amount of money earned from the core business activity of the company.
  • Expenses: It is the total amount required for running the full functionality of the company.
  • Profit or loss:In very simple terms, when a company pays its expenses using its revenue, then what’s left is profit, and in case expenses are more when compared with revenue, then it is loss.
đź“ŚRevenue & Profitability
Revenue/Profitability
Value & Year
2024
2023
2022
Total Revenue 16821343000 14139548000 15415651000
Operating Revenue 16821343000 14139548000 15415651000
Cost Of Revenue 10835229000 9703728000 10609373000
Gross Profit 5986114000 4435820000 4806278000
Ebitda 1725954000 856665000 1567712000
Ebit 1391259000 577361000 1291287000
Operating Income 1251551000 516025000 1090298000
Net Income 961599000 386752000 1016827000
Net Income From Continuing Operation Net Minority Interest 961599000 386752000 1016827000
Net Income From Continuing And Discontinued Operation 961599000 386752000 1016827000
Net Income Common Stockholders 961599000 386752000 1016827000
Net Income Including Noncontrolling Interests 966203000 386755000 1016813000
Net Income Discontinuous Operations - - -
Net Income Continuous Operations 966203000 386755000 1016813000
Normalized Income 961599000 386752000 1016827000
Normalized Ebitda 1725954000 856665000 1567712000
Total Unusual Items - - -
Total Unusual Items Excluding Goodwill - - -
đź“ŚExpenses & Taxes
Expenses/Taxes
Value & Year
2024
2023
2022
Reconciled Depreciation 334695000 279304000 276425000
Reconciled Cost Of Revenue 10835229000 9703728000 10609373000
Total Expenses 15569792000 13623523000 14325353000
Operating Expense 4734563000 3919795000 3715980000
Other Operating Expenses 1222254000 919589000 1060154000
Depreciation And Amortization In Income Statement 334695000 279304000 276425000
Amortization - - -
Depreciation Income Statement 334695000 279304000 276425000
Selling General And Administration 1273146000 1071758000 677649000
Selling And Marketing Expense 1099789000 930136000 535799000
General And Administrative Expense 173357000 141622000 141850000
Rent And Landing Fees 120812000 107401000 81823000
Tax Provision 387954000 170798000 250213000
Pretax Income 1354157000 557553000 1267026000
Other Non Operating Income Expenses 114667000 44760000 89774000
Special Income Charges - - -
Other Special Charges - - -
Write Off - - -
Net Non Operating Interest Income Expense -12061000 -3234000 -10963000
Total Other Finance Cost - - -
Interest Expense Non Operating 37102000 19808000 24261000
Interest Income Non Operating 25041000 16574000 13298000
đź“Ś Earnings Per Share
Earnings Per Share
Value & Year
2024
2023
2022
Diluted Eps 1.88 0.77 1.96
Basic Eps 1.88 0.77 2.26
Diluted Ni Avail To Com Stockholders 961599000 386752000 1016827000
Net Income From Continuing Operations 1354157000 557553000 1267026000
Minority Interests -4604000 -3000 14000

Cash flow analysis for Morepen Laboratories Limited

The cashflow statement in the financial statement of the company shows how cash is moving in or moving out of the company over a period of time.

It consists of the following:

  • Operating activities: Cash flow from the core business operations.
  • Investing activities: Cashflow from investments made by the company.
  • Financing activities: These are cash from loans or by issuing shares or paying out dividends.
đź“ŚOperating Cash Flow
Operating Cash Flow
Value & Year
2024
2023
2022
Operating Cash Flow 733746000 -911706000 -602402000
Changes In Cash -47207000 58632000 -255843000
Taxes Refund Paid -381153000 -165539000 -249323000
Change In Working Capital -581232000 -1582767000 -1814687000
Change In Other Current Liabilities 794768000 -1422764000 516260000
Change In Other Current Assets - - -
Change In Payable - - 24826000
Change In Inventory -197079000 469678000 -1005287000
Change In Receivables -1178921000 -629681000 -1325660000
Other Non Cash Items 37102000 19808000 -73655000
Stock Based Compensation - - -
Provision And Write Off Of Assets - - -
Depreciation And Amortization 334695000 279304000 276425000
Amortization Cash Flow 157810000 155296000 -
Depreciation 176885000 124008000 276425000
đź“ŚInvesting Cash Flow
Investing Cash Flow
Value & Year
2024
2023
2022
Investing Cash Flow -833002000 -465093000 -316785000
Net Other Investing Changes -7169000 -5373000 339813000
Interest Received Cfi - - -
Dividends Received Cfi - - -
Net Investment Purchase And Sale -13010000 - 15411000
Sale Of Investment - - -
Purchase Of Investment - - -
Net Business Purchase And Sale - - -
Sale Of Business - - -
Purchase Of Business - - -
Net Ppe Purchase And Sale -713276000 -356206000 -452791000
Sale Of Ppe 532000 - 1671000
Purchase Of Ppe -713808000 -356206000 -454462000
Net Intangibles Purchase And Sale -99547000 -103514000 -219218000
Purchase Of Intangibles -99547000 -103514000 -219218000
đź“Ś Financing Cash Flow
Financing Cash Flow
Value & Year
2024
2023
2022
Financing Cash Flow 52049000 1435431000 663344000
Net Other Financing Charges 50800000 17768000 123111000
Interest Paid Cff -37102000 -19808000 -
Cash Dividends Paid - - -
Common Stock Dividend Paid - - -
Net Common Stock Issuance - 1371520000 525000000
Common Stock Payments - - -
Common Stock Issuance - 1371520000 525000000
Repurchase Of Capital Stock - - -
Repayment Of Debt - - -
Issuance Of Debt - - -
Issuance Of Capital Stock - 1371520000 525000000
Net Issuance Payments Of Debt 38351000 65951000 15233000
Net Short Term Debt Issuance 14046000 69827000 10305000
Short Term Debt Issuance - - -
Net Long Term Debt Issuance 24305000 -3876000 4928000
Long Term Debt Payments - - -
Long Term Debt Issuance - - -
Net Preferred Stock Issuance - - -
Preferred Stock Payments - - -

Summary

Fundamental Overview of MOREPENLAB.NS (Morepen Laboratories Limited)

Above is the summary for fundamental analysis of Morepen Laboratories Limited , whose ticker name is MOREPENLAB.NS and belongs to sector Healthcare, and it is listed in NSE (National Stock Exchange).

The Morepen Laboratories Limited which is listed in NSE (National Stock Exchange) has a PE ratio of 40.22, MOREPENLAB.NS has a net profit margin of 0.06, the acid test ratio for MOREPENLAB.NS is 1.59, MOREPENLAB.NS has an inventory turnover of 4.36, and MOREPENLAB.NS has debt-to-equity ratio of 0.03.

The MOREPENLAB.NS whose company name is Morepen Laboratories Limited has made profit/loss of 5986114000 with total revenue of 16821343000, MOREPENLAB.NS has assets worth of 12932051000.

1. What is fundamental analysis?

Fundamental analysis is looking into a company’s real business performance by analyzing financial statements, earning reports, and key valuation ratios.

Basically, fundamental analysis involves examining a company’s revenue, profits, losses, debts, assets, liabilities, and ratios calculated using these values to determine long-term investment strategies.

Fundamental analysis may not work for short-term trading of stock; it is usually incorporated by long-term investors.

2. Importance of Fundamental Analysis

Imagine you are locking a good amount of funds into an unknown company for many years. Sounds stupid, right?

This is where fundamental analysis comes into the picture, which turns an unknown enemy into a known friend.

As fundamental analysis involves calculating how a company is actually performing, the real revenue, profits, assets, liabilities, debts, and more. This helps investors to determine what the actual current financial condition of the company is, how much the company’s stock price is justified when compared to earnings (Corporate earnings reports India) that it is making through business, what the probability is that the company will go bankrupt in the future, how much growth the company has shown in the past, and other financial ratios.

All these calculations and analyses determine the financial health of the company, historical business growth, company’s efficiency, and its stock price compared with real earnings (Corporate earnings reports India), which helps traders to make investment decisions for long-term investment strategies.

2. How to Use Our Tool

  • Search for the stock that you want to analyze in the search bar by typing the name of the company or ticker.
  • Once you land on the Stock Analytics Page, click on “Fundamental Analysis”; this will take you to the fundamental analysis page.
  • Apply Filter
  • On the “Fundamental Analysis” page, the first tab is for “Summary and Ratio,” where in the top section you can find the overall summary of the stock’s fundamental analysis, where on the leftmost side it has a textual summary, then in the middle a gauge chart that represents overall financial health, and then a list of important ratios.
  • Apply Filter
  • Then in the same “Summary and Ratio” tab, we have included a detailed analysis of stock in various aspects, which includes “Profitability Analysis,” “Liquidity Analysis,” “Efficiency Analysis,” “Coverage Analysis,” Solvency Analysis,” and “Market Analysis,” which divide the stock’s fundamentals into the above aspects and analyze each in the same format as for overall analysis, where the leftmost side has a textual summary, then in the middle a gauge chart that represents overall analysis of the particular section, and then a list of important ratios. Required for the particular analysis.
  • Apply Filter